European funding petition

  • Dear Colleagues,

    As editor of Pathogens & Global Health I am launching this awareness campaign to support the request that will be made to the European Parliament and Commission to initiate a process of revision of the way priority - and European funding - has been allocated to experimental research. Our concerns are further grounded in the contents of the calls for proposals and the work programmes recently published under Horizon 2020, the new European Framework for Research and Innovation, where the majority of the funding is focused on Public Health, but very little space is given to pure research activities.

    My colleagues and I have started this initiative to make policy makers aware of the current discontent within the community with the view to prompt a future reorientation of the European actions. We therefore ask you to subscribe to this campaign, the results of which will be brought to Brussels.

    Best regards,
    Professor Andrea Crisanti (Professor of Molecular Parasitology – Imperial College London)
    Professor George Christophides (Professor of Infectious Diseases & Immunity – Imperial College London)
    Professor Andy Waters (Professor in Biomedical and Life Sciences – University of Glasgow)

Did you like this? Share it:

A selection of responses to our EC Horizon 2020 e-campaign

We have recently begun an e-campaign that will be made to the European Parliament and Commission to initiate a process of revision of the way priority – and European funding – has been allocated to experimental research.

We have received over 200 replies within the first 24 hours of the campaign, and are seeking to receive 1,000 signatures. Please support our campaign here.

Here is a selection of responses so far:

- It is indeed true that the EU has started to mainly focus on aspects of public health and applied science. To neglect primary, hypothesis-driven research is rather short-sighted, because the results of basic research will be required for any applied science during future decades.

- Additionally, the new programme Horizon 2020 is very much focusing at European matters forgetting about global issues such as global health

- All types of research must be carried out, without an understanding of the basic biology of a pathogen new public health measures will not be developed or understood.

- Given the huge technological advances being made in all areas of biological abd scientific reserach in the post genomic era, it is absolutely vital that we maintain momentum in research by supporting the scientists in the front-line. No more so is this obvious than in the case of antibiotic research, and vector borne diseases, where resistance to antibiotics, insecticides and drugs will wipe out any gains made in disease control. Highquality reserach must run side-by-side with publioc health. It is expensive, no doubt, but to ignore fundamental research risks destroying the priveleged position we are in of finally starting to gain a foothold in tackling tye great diseases of the age.

- Simply, there will be no REAL progress in public health without substantial progress in basic and pure research activities, history teaches us ( not our EC politicians, it would seem!)

- It is important that our colleagues in the Parliament be reminded that most translational research start with the basics and that a balance in wieght of commitment to promoting either is essential to success in Global Health.

- Research in the field of Diseases like Malaria, Tuberculosis and AIDS should be of big interest for the European as well as the worldwide community. Many progresses have been made already and further investigations are strongly needed to add more detailed experimental data so to be able to act at the present moment with a deeper awareness and to find a resolute answer to such global health problems.

- Without pure research into the vectors of disease little more than accepted paradigms will be tested

- Scientific funding should be based on merit and originality. There is a tendency to fund big labs with big names, and this limits the opportunities for younger and/or less powerful scientist.

- Our mission should be to excel in Discovery and Innovation. Application is a bystander. Trying to see impact in everything without fully appreciating the mechanics will surely lead us to adhoc solutions. This kind of approach will keep us in a cycle of spending public money, when actually we are not heading anywhere.

- A balance between pure and applied research is essential as most applied research is based on the knowledge and discoveries made by pure research. Further, it is rare that pure science discoveries are not examined in the light of their potential application to known problems. We would be pursuing medical research half (at least) blind if we did not equally support research into important pure research questions.

Thank you for all those who have supported the campaign so far. If you haven’t, please do so here.

Did you like this? Share it:

Final issues from 2013 now available

untitledThe final two issues of the 2013 volume of PGH is now available. Issue 7 is a themed issue on the topic of Rabies – the issue contains two articles on the intensive efforts to eliminate canine and sylvatic rabies in Italy; and reports on the on-going efforts to control the disease in South America. Issue 8 is a special issue on molecular and population biology of mosquitoes and other disease vectors – the issue includes meeting reports, abstracts and research articles from the 2013 EMBO Kolymbari meeting.

 

Free content available from the issues:

Issue 7: (Rabies)
Editorial
- A note from the International Society of Neglected Tropical Diseases

Issue 8: (Molecular and Population Biology of Mosquitoes and Other Disease Vectors)
- Editorial
Meeting report of the Mosquito Kolymbari Meeting 2013
- INFRAVEC: research capacity for the implementation of genetic control of mosquitoes
- Research article: Discovery and characterisation of two Nimrod superfamily members in Anopheles Gambiae
-
 
Malaria caused by Plasmodium Vivax
- Research articles: Cell biological analysis of mosquito midgut invasion
Meeting report of Climate & Human Health, Cyprus 17-19 October 2012

All content of 2013′s volume can be found here

Did you like this? Share it:

Issue 5 available online

PGH-107_5-shadow-RGBIssue 5 of the 2013 volume of Pathogens and Global Health is now online. The issue contains a review on the avian influenza strains causing outbreaks in human populations. And a review about the role of environmental variables on the dengue and chikungunya vector Aedes albopictus.

The rest of the issue is available here.

Did you like this? Share it:

Issue 4 available online

PGHIssue4Issue 4 of the 2013 volume of Pathogens and Global Health is online. The issue contains a paper that explores the current issues concerning the genetic control of Aedes mosquitoes and a look at human toxoplasmosis infection: A review on antibiotics and the infection’s prevalence in the severely mentally ill.

The rest of the issue is available here.

Did you like this? Share it:

Issue 3 available online

PGH-107_3-shadow-RGB_thumbIssue 3 of the 2013 volume of Pathogens and Global Health is online. The issue contains a paper that explores the targeting of vitamin A as a treatment for Malaria and a review article that looks at the relationship between allergic diseases and helminth infections.

The rest of the issue is available here.

Did you like this? Share it: